Redefining Risk in Acute Coronary Syndromes Using Molecular Medicine
Keywords: بیماری سرخرگ تاجی یا بیماری شریان کرونری; ACS, acute coronary syndrome; CAD, coronary artery disease; CRP, C-reactive protein; EPC, endothelial progenitor cells; GP, glycoprotein; FLAP, 5-lipoxygenase activating protein pathway; LDL, low-density lipoprotein; MI, myocardial infarction